<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref35">
 <mixed-citation publication-type="journal" id="cit35">
  <name>
   <surname>Papp</surname>
   <given-names>I.</given-names>
  </name>; 
  <name>
   <surname>Sieben</surname>
   <given-names>C.</given-names>
  </name>; 
  <name>
   <surname>Ludwig</surname>
   <given-names>K.</given-names>
  </name>; 
  <name>
   <surname>Roskamp</surname>
   <given-names>M.</given-names>
  </name>; 
  <name>
   <surname>Böttcher</surname>
   <given-names>C.</given-names>
  </name>; 
  <name>
   <surname>Schlecht</surname>
   <given-names>S.</given-names>
  </name>; 
  <name>
   <surname>Herrmann</surname>
   <given-names>A.</given-names>
  </name>; 
  <name>
   <surname>Haag</surname>
   <given-names>R.</given-names>
  </name>
  <article-title>Inhibition of Influenza Virus Infection by Multivalent Sialic-Acid- Functionalized Gold Nanoparticles</article-title>. 
  <source>Small</source>
  <year>2010</year>, 
  <volume>6</volume>, 
  <fpage>2900</fpage>–
  <lpage>2906</lpage>. 
  <pub-id pub-id-type="doi">10.1002/smll.201001349</pub-id>.
  <pub-id pub-id-type="pmid">21104827</pub-id>
 </mixed-citation>
</ref>
